The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Organ Transplant Rejection Medicine Market Research Report 2025
Synopsis
Organ Transplant Rejection Medicine have enhanced short-term graft survival and minimized the rate of acute organ transplant rejection.
The global Organ Transplant Rejection Medicine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Organ Transplant Rejection Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Organ Transplant Rejection Medicine.
Report Scope
The Organ Transplant Rejection Medicine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Organ Transplant Rejection Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Organ Transplant Rejection Medicine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline plc
Novartis AG
F. Hoffmann-La Roche Ltd.
Astellas Pharma, Inc.
Pfizer, Inc.
AbbVie, Inc.
Allergan plc.
Bristol-Myers Squibb Company
Sanofi
Segment by Type
Steroids
Antibodies
mTOR Inhibitors
Antiproliferative Agents
Calcineurin Inhibitors
Segment by Application
Kidney Transplant
Bone Marrow Transplant
Liver Transplant
Heart Transplant
Lung Transplant
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Organ Transplant Rejection Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Organ Transplant Rejection Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Organ Transplant Rejection Medicine have enhanced short-term graft survival and minimized the rate of acute organ transplant rejection.
The global Organ Transplant Rejection Medicine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Organ Transplant Rejection Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Organ Transplant Rejection Medicine.
Report Scope
The Organ Transplant Rejection Medicine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Organ Transplant Rejection Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Organ Transplant Rejection Medicine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline plc
Novartis AG
F. Hoffmann-La Roche Ltd.
Astellas Pharma, Inc.
Pfizer, Inc.
AbbVie, Inc.
Allergan plc.
Bristol-Myers Squibb Company
Sanofi
Segment by Type
Steroids
Antibodies
mTOR Inhibitors
Antiproliferative Agents
Calcineurin Inhibitors
Segment by Application
Kidney Transplant
Bone Marrow Transplant
Liver Transplant
Heart Transplant
Lung Transplant
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Organ Transplant Rejection Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Organ Transplant Rejection Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Organ Transplant Rejection Medicine Market Overview
1.1 Product Overview and Scope of Organ Transplant Rejection Medicine
1.2 Organ Transplant Rejection Medicine Segment by Type
1.2.1 Global Organ Transplant Rejection Medicine Market Value Comparison by Type (2024-2030)
1.2.2 Steroids
1.2.3 Antibodies
1.2.4 mTOR Inhibitors
1.2.5 Antiproliferative Agents
1.2.6 Calcineurin Inhibitors
1.3 Organ Transplant Rejection Medicine Segment by Application
1.3.1 Global Organ Transplant Rejection Medicine Market Value by Application: (2024-2030)
1.3.2 Kidney Transplant
1.3.3 Bone Marrow Transplant
1.3.4 Liver Transplant
1.3.5 Heart Transplant
1.3.6 Lung Transplant
1.3.7 Others
1.4 Global Organ Transplant Rejection Medicine Market Size Estimates and Forecasts
1.4.1 Global Organ Transplant Rejection Medicine Revenue 2019-2030
1.4.2 Global Organ Transplant Rejection Medicine Sales 2019-2030
1.4.3 Global Organ Transplant Rejection Medicine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Organ Transplant Rejection Medicine Market Competition by Manufacturers
2.1 Global Organ Transplant Rejection Medicine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Organ Transplant Rejection Medicine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Organ Transplant Rejection Medicine Average Price by Manufacturers (2019-2024)
2.4 Global Organ Transplant Rejection Medicine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Organ Transplant Rejection Medicine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Organ Transplant Rejection Medicine, Product Type & Application
2.7 Organ Transplant Rejection Medicine Market Competitive Situation and Trends
2.7.1 Organ Transplant Rejection Medicine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Organ Transplant Rejection Medicine Players Market Share by Revenue
2.7.3 Global Organ Transplant Rejection Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Organ Transplant Rejection Medicine Retrospective Market Scenario by Region
3.1 Global Organ Transplant Rejection Medicine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Organ Transplant Rejection Medicine Global Organ Transplant Rejection Medicine Sales by Region: 2019-2030
3.2.1 Global Organ Transplant Rejection Medicine Sales by Region: 2019-2024
3.2.2 Global Organ Transplant Rejection Medicine Sales by Region: 2025-2030
3.3 Global Organ Transplant Rejection Medicine Global Organ Transplant Rejection Medicine Revenue by Region: 2019-2030
3.3.1 Global Organ Transplant Rejection Medicine Revenue by Region: 2019-2024
3.3.2 Global Organ Transplant Rejection Medicine Revenue by Region: 2025-2030
3.4 North America Organ Transplant Rejection Medicine Market Facts & Figures by Country
3.4.1 North America Organ Transplant Rejection Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Organ Transplant Rejection Medicine Sales by Country (2019-2030)
3.4.3 North America Organ Transplant Rejection Medicine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Organ Transplant Rejection Medicine Market Facts & Figures by Country
3.5.1 Europe Organ Transplant Rejection Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Organ Transplant Rejection Medicine Sales by Country (2019-2030)
3.5.3 Europe Organ Transplant Rejection Medicine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Organ Transplant Rejection Medicine Market Facts & Figures by Country
3.6.1 Asia Pacific Organ Transplant Rejection Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Organ Transplant Rejection Medicine Sales by Country (2019-2030)
3.6.3 Asia Pacific Organ Transplant Rejection Medicine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Organ Transplant Rejection Medicine Market Facts & Figures by Country
3.7.1 Latin America Organ Transplant Rejection Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Organ Transplant Rejection Medicine Sales by Country (2019-2030)
3.7.3 Latin America Organ Transplant Rejection Medicine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Organ Transplant Rejection Medicine Market Facts & Figures by Country
3.8.1 Middle East and Africa Organ Transplant Rejection Medicine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Organ Transplant Rejection Medicine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Organ Transplant Rejection Medicine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Organ Transplant Rejection Medicine Sales by Type (2019-2030)
4.1.1 Global Organ Transplant Rejection Medicine Sales by Type (2019-2024)
4.1.2 Global Organ Transplant Rejection Medicine Sales by Type (2025-2030)
4.1.3 Global Organ Transplant Rejection Medicine Sales Market Share by Type (2019-2030)
4.2 Global Organ Transplant Rejection Medicine Revenue by Type (2019-2030)
4.2.1 Global Organ Transplant Rejection Medicine Revenue by Type (2019-2024)
4.2.2 Global Organ Transplant Rejection Medicine Revenue by Type (2025-2030)
4.2.3 Global Organ Transplant Rejection Medicine Revenue Market Share by Type (2019-2030)
4.3 Global Organ Transplant Rejection Medicine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Organ Transplant Rejection Medicine Sales by Application (2019-2030)
5.1.1 Global Organ Transplant Rejection Medicine Sales by Application (2019-2024)
5.1.2 Global Organ Transplant Rejection Medicine Sales by Application (2025-2030)
5.1.3 Global Organ Transplant Rejection Medicine Sales Market Share by Application (2019-2030)
5.2 Global Organ Transplant Rejection Medicine Revenue by Application (2019-2030)
5.2.1 Global Organ Transplant Rejection Medicine Revenue by Application (2019-2024)
5.2.2 Global Organ Transplant Rejection Medicine Revenue by Application (2025-2030)
5.2.3 Global Organ Transplant Rejection Medicine Revenue Market Share by Application (2019-2030)
5.3 Global Organ Transplant Rejection Medicine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GlaxoSmithKline plc
6.1.1 GlaxoSmithKline plc Corporation Information
6.1.2 GlaxoSmithKline plc Description and Business Overview
6.1.3 GlaxoSmithKline plc Organ Transplant Rejection Medicine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GlaxoSmithKline plc Organ Transplant Rejection Medicine Product Portfolio
6.1.5 GlaxoSmithKline plc Recent Developments/Updates
6.2 Novartis AG
6.2.1 Novartis AG Corporation Information
6.2.2 Novartis AG Description and Business Overview
6.2.3 Novartis AG Organ Transplant Rejection Medicine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Novartis AG Organ Transplant Rejection Medicine Product Portfolio
6.2.5 Novartis AG Recent Developments/Updates
6.3 F. Hoffmann-La Roche Ltd.
6.3.1 F. Hoffmann-La Roche Ltd. Corporation Information
6.3.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
6.3.3 F. Hoffmann-La Roche Ltd. Organ Transplant Rejection Medicine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 F. Hoffmann-La Roche Ltd. Organ Transplant Rejection Medicine Product Portfolio
6.3.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
6.4 Astellas Pharma, Inc.
6.4.1 Astellas Pharma, Inc. Corporation Information
6.4.2 Astellas Pharma, Inc. Description and Business Overview
6.4.3 Astellas Pharma, Inc. Organ Transplant Rejection Medicine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Astellas Pharma, Inc. Organ Transplant Rejection Medicine Product Portfolio
6.4.5 Astellas Pharma, Inc. Recent Developments/Updates
6.5 Pfizer, Inc.
6.5.1 Pfizer, Inc. Corporation Information
6.5.2 Pfizer, Inc. Description and Business Overview
6.5.3 Pfizer, Inc. Organ Transplant Rejection Medicine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Pfizer, Inc. Organ Transplant Rejection Medicine Product Portfolio
6.5.5 Pfizer, Inc. Recent Developments/Updates
6.6 AbbVie, Inc.
6.6.1 AbbVie, Inc. Corporation Information
6.6.2 AbbVie, Inc. Description and Business Overview
6.6.3 AbbVie, Inc. Organ Transplant Rejection Medicine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 AbbVie, Inc. Organ Transplant Rejection Medicine Product Portfolio
6.6.5 AbbVie, Inc. Recent Developments/Updates
6.7 Allergan plc.
6.6.1 Allergan plc. Corporation Information
6.6.2 Allergan plc. Description and Business Overview
6.6.3 Allergan plc. Organ Transplant Rejection Medicine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Allergan plc. Organ Transplant Rejection Medicine Product Portfolio
6.7.5 Allergan plc. Recent Developments/Updates
6.8 Bristol-Myers Squibb Company
6.8.1 Bristol-Myers Squibb Company Corporation Information
6.8.2 Bristol-Myers Squibb Company Description and Business Overview
6.8.3 Bristol-Myers Squibb Company Organ Transplant Rejection Medicine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bristol-Myers Squibb Company Organ Transplant Rejection Medicine Product Portfolio
6.8.5 Bristol-Myers Squibb Company Recent Developments/Updates
6.9 Sanofi
6.9.1 Sanofi Corporation Information
6.9.2 Sanofi Description and Business Overview
6.9.3 Sanofi Organ Transplant Rejection Medicine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Sanofi Organ Transplant Rejection Medicine Product Portfolio
6.9.5 Sanofi Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Organ Transplant Rejection Medicine Industry Chain Analysis
7.2 Organ Transplant Rejection Medicine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Organ Transplant Rejection Medicine Production Mode & Process
7.4 Organ Transplant Rejection Medicine Sales and Marketing
7.4.1 Organ Transplant Rejection Medicine Sales Channels
7.4.2 Organ Transplant Rejection Medicine Distributors
7.5 Organ Transplant Rejection Medicine Customers
8 Organ Transplant Rejection Medicine Market Dynamics
8.1 Organ Transplant Rejection Medicine Industry Trends
8.2 Organ Transplant Rejection Medicine Market Drivers
8.3 Organ Transplant Rejection Medicine Market Challenges
8.4 Organ Transplant Rejection Medicine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Organ Transplant Rejection Medicine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Organ Transplant Rejection Medicine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Organ Transplant Rejection Medicine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Organ Transplant Rejection Medicine Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Organ Transplant Rejection Medicine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Organ Transplant Rejection Medicine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Organ Transplant Rejection Medicine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Organ Transplant Rejection Medicine Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Organ Transplant Rejection Medicine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Organ Transplant Rejection Medicine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Organ Transplant Rejection Medicine, Product Type & Application
Table 12. Global Key Manufacturers of Organ Transplant Rejection Medicine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Organ Transplant Rejection Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Organ Transplant Rejection Medicine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Organ Transplant Rejection Medicine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Organ Transplant Rejection Medicine Sales by Region (2019-2024) & (K Units)
Table 18. Global Organ Transplant Rejection Medicine Sales Market Share by Region (2019-2024)
Table 19. Global Organ Transplant Rejection Medicine Sales by Region (2025-2030) & (K Units)
Table 20. Global Organ Transplant Rejection Medicine Sales Market Share by Region (2025-2030)
Table 21. Global Organ Transplant Rejection Medicine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Organ Transplant Rejection Medicine Revenue Market Share by Region (2019-2024)
Table 23. Global Organ Transplant Rejection Medicine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Organ Transplant Rejection Medicine Revenue Market Share by Region (2025-2030)
Table 25. North America Organ Transplant Rejection Medicine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Organ Transplant Rejection Medicine Sales by Country (2019-2024) & (K Units)
Table 27. North America Organ Transplant Rejection Medicine Sales by Country (2025-2030) & (K Units)
Table 28. North America Organ Transplant Rejection Medicine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Organ Transplant Rejection Medicine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Organ Transplant Rejection Medicine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Organ Transplant Rejection Medicine Sales by Country (2019-2024) & (K Units)
Table 32. Europe Organ Transplant Rejection Medicine Sales by Country (2025-2030) & (K Units)
Table 33. Europe Organ Transplant Rejection Medicine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Organ Transplant Rejection Medicine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Organ Transplant Rejection Medicine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Organ Transplant Rejection Medicine Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Organ Transplant Rejection Medicine Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Organ Transplant Rejection Medicine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Organ Transplant Rejection Medicine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Organ Transplant Rejection Medicine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Organ Transplant Rejection Medicine Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Organ Transplant Rejection Medicine Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Organ Transplant Rejection Medicine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Organ Transplant Rejection Medicine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Organ Transplant Rejection Medicine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Organ Transplant Rejection Medicine Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Organ Transplant Rejection Medicine Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Organ Transplant Rejection Medicine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Organ Transplant Rejection Medicine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Organ Transplant Rejection Medicine Sales (K Units) by Type (2019-2024)
Table 51. Global Organ Transplant Rejection Medicine Sales (K Units) by Type (2025-2030)
Table 52. Global Organ Transplant Rejection Medicine Sales Market Share by Type (2019-2024)
Table 53. Global Organ Transplant Rejection Medicine Sales Market Share by Type (2025-2030)
Table 54. Global Organ Transplant Rejection Medicine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Organ Transplant Rejection Medicine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Organ Transplant Rejection Medicine Revenue Market Share by Type (2019-2024)
Table 57. Global Organ Transplant Rejection Medicine Revenue Market Share by Type (2025-2030)
Table 58. Global Organ Transplant Rejection Medicine Price (USD/Unit) by Type (2019-2024)
Table 59. Global Organ Transplant Rejection Medicine Price (USD/Unit) by Type (2025-2030)
Table 60. Global Organ Transplant Rejection Medicine Sales (K Units) by Application (2019-2024)
Table 61. Global Organ Transplant Rejection Medicine Sales (K Units) by Application (2025-2030)
Table 62. Global Organ Transplant Rejection Medicine Sales Market Share by Application (2019-2024)
Table 63. Global Organ Transplant Rejection Medicine Sales Market Share by Application (2025-2030)
Table 64. Global Organ Transplant Rejection Medicine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Organ Transplant Rejection Medicine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Organ Transplant Rejection Medicine Revenue Market Share by Application (2019-2024)
Table 67. Global Organ Transplant Rejection Medicine Revenue Market Share by Application (2025-2030)
Table 68. Global Organ Transplant Rejection Medicine Price (USD/Unit) by Application (2019-2024)
Table 69. Global Organ Transplant Rejection Medicine Price (USD/Unit) by Application (2025-2030)
Table 70. GlaxoSmithKline plc Corporation Information
Table 71. GlaxoSmithKline plc Description and Business Overview
Table 72. GlaxoSmithKline plc Organ Transplant Rejection Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. GlaxoSmithKline plc Organ Transplant Rejection Medicine Product
Table 74. GlaxoSmithKline plc Recent Developments/Updates
Table 75. Novartis AG Corporation Information
Table 76. Novartis AG Description and Business Overview
Table 77. Novartis AG Organ Transplant Rejection Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Novartis AG Organ Transplant Rejection Medicine Product
Table 79. Novartis AG Recent Developments/Updates
Table 80. F. Hoffmann-La Roche Ltd. Corporation Information
Table 81. F. Hoffmann-La Roche Ltd. Description and Business Overview
Table 82. F. Hoffmann-La Roche Ltd. Organ Transplant Rejection Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. F. Hoffmann-La Roche Ltd. Organ Transplant Rejection Medicine Product
Table 84. F. Hoffmann-La Roche Ltd. Recent Developments/Updates
Table 85. Astellas Pharma, Inc. Corporation Information
Table 86. Astellas Pharma, Inc. Description and Business Overview
Table 87. Astellas Pharma, Inc. Organ Transplant Rejection Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Astellas Pharma, Inc. Organ Transplant Rejection Medicine Product
Table 89. Astellas Pharma, Inc. Recent Developments/Updates
Table 90. Pfizer, Inc. Corporation Information
Table 91. Pfizer, Inc. Description and Business Overview
Table 92. Pfizer, Inc. Organ Transplant Rejection Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Pfizer, Inc. Organ Transplant Rejection Medicine Product
Table 94. Pfizer, Inc. Recent Developments/Updates
Table 95. AbbVie, Inc. Corporation Information
Table 96. AbbVie, Inc. Description and Business Overview
Table 97. AbbVie, Inc. Organ Transplant Rejection Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. AbbVie, Inc. Organ Transplant Rejection Medicine Product
Table 99. AbbVie, Inc. Recent Developments/Updates
Table 100. Allergan plc. Corporation Information
Table 101. Allergan plc. Description and Business Overview
Table 102. Allergan plc. Organ Transplant Rejection Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Allergan plc. Organ Transplant Rejection Medicine Product
Table 104. Allergan plc. Recent Developments/Updates
Table 105. Bristol-Myers Squibb Company Corporation Information
Table 106. Bristol-Myers Squibb Company Description and Business Overview
Table 107. Bristol-Myers Squibb Company Organ Transplant Rejection Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Bristol-Myers Squibb Company Organ Transplant Rejection Medicine Product
Table 109. Bristol-Myers Squibb Company Recent Developments/Updates
Table 110. Sanofi Corporation Information
Table 111. Sanofi Description and Business Overview
Table 112. Sanofi Organ Transplant Rejection Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Sanofi Organ Transplant Rejection Medicine Product
Table 114. Sanofi Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Organ Transplant Rejection Medicine Distributors List
Table 118. Organ Transplant Rejection Medicine Customers List
Table 119. Organ Transplant Rejection Medicine Market Trends
Table 120. Organ Transplant Rejection Medicine Market Drivers
Table 121. Organ Transplant Rejection Medicine Market Challenges
Table 122. Organ Transplant Rejection Medicine Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Organ Transplant Rejection Medicine
Figure 2. Global Organ Transplant Rejection Medicine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Organ Transplant Rejection Medicine Market Share by Type in 2023 & 2030
Figure 4. Steroids Product Picture
Figure 5. Antibodies Product Picture
Figure 6. mTOR Inhibitors Product Picture
Figure 7. Antiproliferative Agents Product Picture
Figure 8. Calcineurin Inhibitors Product Picture
Figure 9. Global Organ Transplant Rejection Medicine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Organ Transplant Rejection Medicine Market Share by Application in 2023 & 2030
Figure 11. Kidney Transplant
Figure 12. Bone Marrow Transplant
Figure 13. Liver Transplant
Figure 14. Heart Transplant
Figure 15. Lung Transplant
Figure 16. Others
Figure 17. Global Organ Transplant Rejection Medicine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Organ Transplant Rejection Medicine Market Size (2019-2030) & (US$ Million)
Figure 19. Global Organ Transplant Rejection Medicine Sales (2019-2030) & (K Units)
Figure 20. Global Organ Transplant Rejection Medicine Average Price (USD/Unit) & (2019-2030)
Figure 21. Organ Transplant Rejection Medicine Report Years Considered
Figure 22. Organ Transplant Rejection Medicine Sales Share by Manufacturers in 2023
Figure 23. Global Organ Transplant Rejection Medicine Revenue Share by Manufacturers in 2023
Figure 24. The Global 5 and 10 Largest Organ Transplant Rejection Medicine Players: Market Share by Revenue in 2023
Figure 25. Organ Transplant Rejection Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 26. Global Organ Transplant Rejection Medicine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 27. North America Organ Transplant Rejection Medicine Sales Market Share by Country (2019-2030)
Figure 28. North America Organ Transplant Rejection Medicine Revenue Market Share by Country (2019-2030)
Figure 29. United States Organ Transplant Rejection Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Canada Organ Transplant Rejection Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Europe Organ Transplant Rejection Medicine Sales Market Share by Country (2019-2030)
Figure 32. Europe Organ Transplant Rejection Medicine Revenue Market Share by Country (2019-2030)
Figure 33. Germany Organ Transplant Rejection Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. France Organ Transplant Rejection Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. U.K. Organ Transplant Rejection Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Italy Organ Transplant Rejection Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Russia Organ Transplant Rejection Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Asia Pacific Organ Transplant Rejection Medicine Sales Market Share by Region (2019-2030)
Figure 39. Asia Pacific Organ Transplant Rejection Medicine Revenue Market Share by Region (2019-2030)
Figure 40. China Organ Transplant Rejection Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Japan Organ Transplant Rejection Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. South Korea Organ Transplant Rejection Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. India Organ Transplant Rejection Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Australia Organ Transplant Rejection Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. China Taiwan Organ Transplant Rejection Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Indonesia Organ Transplant Rejection Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Thailand Organ Transplant Rejection Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Malaysia Organ Transplant Rejection Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Latin America Organ Transplant Rejection Medicine Sales Market Share by Country (2019-2030)
Figure 50. Latin America Organ Transplant Rejection Medicine Revenue Market Share by Country (2019-2030)
Figure 51. Mexico Organ Transplant Rejection Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Brazil Organ Transplant Rejection Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Argentina Organ Transplant Rejection Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Middle East & Africa Organ Transplant Rejection Medicine Sales Market Share by Country (2019-2030)
Figure 55. Middle East & Africa Organ Transplant Rejection Medicine Revenue Market Share by Country (2019-2030)
Figure 56. Turkey Organ Transplant Rejection Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Saudi Arabia Organ Transplant Rejection Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 58. UAE Organ Transplant Rejection Medicine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 59. Global Sales Market Share of Organ Transplant Rejection Medicine by Type (2019-2030)
Figure 60. Global Revenue Market Share of Organ Transplant Rejection Medicine by Type (2019-2030)
Figure 61. Global Organ Transplant Rejection Medicine Price (USD/Unit) by Type (2019-2030)
Figure 62. Global Sales Market Share of Organ Transplant Rejection Medicine by Application (2019-2030)
Figure 63. Global Revenue Market Share of Organ Transplant Rejection Medicine by Application (2019-2030)
Figure 64. Global Organ Transplant Rejection Medicine Price (USD/Unit) by Application (2019-2030)
Figure 65. Organ Transplant Rejection Medicine Value Chain
Figure 66. Organ Transplant Rejection Medicine Production Process
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Distributors Profiles
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
